• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

$1.9 million NIH grant to Wayne State to develop novel therapy for…

Bioengineer by Bioengineer
January 23, 2018
in Biology, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Wayne State University

DETROIT – Wayne State University recently received a five-year, $1.925 million grant from the National Eye Institute of the National Institutes of Health to test the role of microRNAs (miRNAs) — a newly recognized level of gene expression regulation — in bacterial keratitis – an infection of the cornea caused by bacteria — as well as to identify new therapeutic targets and alternative treatment strategies.

According to the research team led by Shunbin Xu, M.D., Ph.D., associate professor of ophthalmology and anatomy and cell biology in the School of Medicine at Wayne State University, Pseudomonas aeruginosa (PA)-induced keratitis is one of the most rapidly developing and destructive diseases of the cornea and a global cause of visual impairment and blindness. It is also one of the most causative organisms of contact lens-related diseases in developed countries.

Xu, along with Linda Hazlett, Ph.D., interim vice dean for research and graduate programs in Wayne State's School of Medicine, will test the role of the miR-183/96/182 cluster and the mechanisms by which it regulates the innate immune response to PA infection, as well as the potential of knockdown of the cluster function by anti-miRs to protect the cornea from adverse effects of the disease.

"In our previous studies, we discovered that anti-miR-183/96/182 enhances the ability of innate immune cells — including macrophages and neutrophils from our blood — to engulf and kill bacteria," said Xu. "This also limits inflammatory responses and collateral damage to the corneal tissue.

"Through our research, we hope that novel therapies will be developed for treatment of corneal bacterial infections in contact lens users as well as injured soldiers in the battle field."

The goal of this grant, "The miR-183/96/182 Cluster in Pseudomonas Aeruginosa-Induced Keratitis," is to uncover the underlying molecular mechanisms by which the cluster enhances the innate immunity, which may lead to development of new approaches to combat antibiotic-resistant bacterial infections and tumors, which evade the surveillance of our innate immune system.

The award number for this National Eye Institute of the National Institutes of Health grant is EY026059.

###

About Wayne State University

Wayne State University is one of the nation's pre-eminent public research universities in an urban setting. Through its multidisciplinary approach to research and education, and its ongoing collaboration with government, industry and other institutions, the university seeks to enhance economic growth and improve the quality of life in the city of Detroit, state of Michigan and throughout the world. For more information about research at Wayne State University, visit research.wayne.edu.

Media Contact

Julie O'Connor
[email protected]
313-577-8845

http://www.research.wayne.edu/about/index.php

Original Source

http://research.wayne.edu/news/wayne-state-receives-19-m-nih-grant-to-develop-novel-therapy-for-corneal-bacterial-infection-23294

Share12Tweet8Share2ShareShareShare2

Related Posts

Unveiling the Biological Pathways Linking Pesticides to Cancer Risk: New Study Sheds Light on Environmental Health Impacts

April 1, 2026

Inequities in Family Engagement Within the NICU

April 1, 2026

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

April 1, 2026

Frailty, Malnutrition Link Falls to Daily Functioning

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unveiling the Biological Pathways Linking Pesticides to Cancer Risk: New Study Sheds Light on Environmental Health Impacts

Inequities in Family Engagement Within the NICU

FGFR2b Links to Biomarkers, Tumor Diversity, Survival

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.